Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Jul 14, 2026

Accession no.
0001106578-26-000097
Filed
Jul 14, 2026, 4:34 PM ET
Trade date
Jul 13, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.09M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (Chairperson & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 13, 2026Common StockMOption exerciseAcquired+9,500$135.42+$1,286,49050,013Direct
Jul 13, 2026Common StockSSaleDisposed−1,020$533.70F2−$544,376.2448,993Direct
Jul 13, 2026Common StockSSaleDisposed−2,272$534.63F3−$1,214,669.3646,721Direct
Jul 13, 2026Common StockSSaleDisposed−2,191$535.47F4−$1,173,213.4644,530Direct
Jul 13, 2026Common StockSSaleDisposed−2,223$536.52F5−$1,192,674.442,307Direct
Jul 13, 2026Common StockSSaleDisposed−665$537.66F6−$357,545.3641,642Direct
Jul 13, 2026Common StockSSaleDisposed−409$538.60F7−$220,289.3241,233Direct
Jul 13, 2026Common StockSSaleDisposed−320$539.60F8−$172,673.4140,913Direct
Jul 13, 2026Common StockSSaleDisposed−360$541.10F9−$194,795.8940,553Direct
Jul 13, 2026Common StockSSaleDisposed−40$542.80−$21,71240,513Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 13, 2026Common StockMOption exerciseDisposed−9,500$0.00$011,218Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $533.04 to $534.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $534.05 to $535.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $535.05 to $536.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $536.05 to $537.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $537.09 to $538.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $538.10 to $539.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $539.25 to $540.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $540.57 to $541.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)